Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Safety and Efficacy of Shenyankangfu Tablets for Chronic Kidney Disease

NCT02885857 is registered in ClinicalTrials.gov with Chen Xiangmei as lead sponsor.

NCT NCT02885857
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02885857 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Safety and Efficacy of Shenyankangfu Tablets for Chronic Kidney Disease
Lead sponsor
Chen Xiangmei
Phase
Phase 4
Overall status
Unknown status
Start date
June 30, 2015
Completion date
December 31, 2016
Enrollment
1,500 (estimated)
Sites
13

Conditions

As the registry lists them; a condition with its own page is linked.

chronic kidney disease